Literature DB >> 9551845

Inhibition of pentylenetetrazol-induced seizures in rats by prostaglandin D2.

E S Akarsu1, S Mamuk, A Comert.   

Abstract

This study was undertaken to evaluate the role of brain PGD2 activity during PTZ induced seizures in rats. Potentiation of endogenous PGD2 activity caused an anti-convulsant effect. Thus, after PGD2 injection (5 microg/icv) the latency of generalized tonic clonic convulsions was prolonged. ZK 118.182, a stable analogue of PGD2, dose-dependently inhibited the incidence and the intensity of seizures when injected at doses of 1-100 ng/icv. But on the other hand, inhibition of PGD2 activity either by a D-type PG receptor antagonist (AH 6809; 50 ng/icv) or by a PGD synthase inhibitor (sodium selenite; 0.2 microg/icv) produced a proconvulsant effect by increasing the incidence and the intensity of the seizures. These findings indicate that endogenous PGD2 activity in the brain may have a specific inhibitory role for the initiation and propagation of PTZ induced seizures in rats.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551845     DOI: 10.1016/s0920-1211(97)00092-2

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  9 in total

Review 1.  Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus.

Authors:  Yifeng Du; Timothy Kemper; Jiange Qiu; Jianxiong Jiang
Journal:  Expert Rev Neurother       Date:  2016-01-13       Impact factor: 4.618

Review 2.  G protein-coupled receptors in acquired epilepsy: Druggability and translatability.

Authors:  Ying Yu; Davis T Nguyen; Jianxiong Jiang
Journal:  Prog Neurobiol       Date:  2019-08-24       Impact factor: 11.685

3.  Neuromodulatory role of endogenous interleukin-1β in acute seizures: possible contribution of cyclooxygenase-2.

Authors:  Robert J Claycomb; Sandra J Hewett; James A Hewett
Journal:  Neurobiol Dis       Date:  2011-08-10       Impact factor: 5.996

4.  Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2.

Authors:  Jianxiong Jiang; Thota Ganesh; Yuhong Du; Yi Quan; Geidy Serrano; Min Qui; Iris Speigel; Asheebo Rojas; Nadia Lelutiu; Raymond Dingledine
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-08       Impact factor: 11.205

5.  Altered GABAergic neurotransmission is associated with increased kainate-induced seizure in prostaglandin-endoperoxide synthase-2 deficient mice.

Authors:  Christopher D Toscano; Yumi Ueda; York A Tomita; Stefano Vicini; Francesca Bosetti
Journal:  Brain Res Bull       Date:  2007-11-09       Impact factor: 4.077

6.  Intra-hippocampal injection of lipopolysaccharide inhibits kindled seizures and retards kindling rate in adult rats.

Authors:  Amin Ahmadi; Mohammad Sayyah; Baharak Khoshkholgh-Sima; Samira Choopani; Jafar Kazemi; Mehdi Sadegh; Farshad Moradpour; Hossein Nahrevanian
Journal:  Exp Brain Res       Date:  2013-02-01       Impact factor: 1.972

Review 7.  Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.

Authors:  Avijit Dey; Xu Kang; Jiange Qiu; Yifeng Du; Jianxiong Jiang
Journal:  Trends Pharmacol Sci       Date:  2016-04-06       Impact factor: 14.819

8.  Maintenance of the Innate Seizure Threshold by Cyclooxygenase-2 is Not Influenced by the Translational Silencer, T-cell Intracellular Antigen-1.

Authors:  Yifan Gong; James A Hewett
Journal:  Neuroscience       Date:  2018-01-11       Impact factor: 3.590

9.  Systemic delivery of antagomirs during blood-brain barrier disruption is disease-modifying in experimental epilepsy.

Authors:  Cristina R Reschke; Luiz F A Silva; Vamshidhar R Vangoor; Massimo Rosso; Bastian David; Brenton L Cavanagh; Niamh M C Connolly; Gary P Brennan; Amaya Sanz-Rodriguez; Catherine Mooney; Aasia Batool; Chris Greene; Marian Brennan; Ronan M Conroy; Theodor Rüber; Jochen H M Prehn; Matthew Campbell; R Jeroen Pasterkamp; David C Henshall
Journal:  Mol Ther       Date:  2021-02-18       Impact factor: 12.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.